Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
De novo belatacept does not reduce the rate of skin cance... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy
0
Authors
Olivia Jew
8 more
Olivia Jew
•
Winston Liu
6 more
•
Melodi Whitley
Published
June 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of the American Academy of Dermatology
Topics
Medicine
Cancer Oncology
Epidemiology
Immunology
Internal Medicine
Show all topics
DOI
10.1016/j.jaad.2024.05.068
